Status:
COMPLETED
Feasibility Controlled Trial of an 8-session Group Intervention for Siblings of Children Who Have ASD
Lead Sponsor:
University of Surrey
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
7-11 years
Phase:
NA
Brief Summary
A feasibility controlled trial of an eight-session group intervention for siblings of children who have an Autism Spectrum Disorder (ASD). Children will be recruited from a multi-academy trust of nin...
Eligibility Criteria
Inclusion
- 7-11 years old.
- Must have a sibling who has a formal diagnosis of ASD.
- Must be competent in the English language.
- Must be in mainstream education.
- Must be willing and able to engage in an eight-session group intervention (including being accompanied to and from the group by their parents/carers).
- Must be registered with a GP and parental consent gained to inform the GP that the sibling is attending the group.
Exclusion
- If the sibling has a diagnosis of ASD themselves.
- If there are any clear risk concerns (e.g. any thought or intent to harm self or others, involvement in court proceedings or with the criminal justice system).
- If the sibling is currently receiving any other psychological treatment.
- If the sibling has a learning disability or difficulty that will make it hard to access the group content and/or capacity to provide informed consent.
Key Trial Info
Start Date :
December 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04714606
Start Date
December 14 2020
End Date
April 30 2021
Last Update
June 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Howard Partnership Multi-Academy Trust
Leatherhead, United Kingdom, KT24 5JR